Kling Biotherapeutics to Present Key Applications for its Primary B-Cell Immortalization, Screening and Antibody Optimization Platform Technologies at PEGS Europe Kling-Select is a uniquely promising approach to identifying novel targets and therapeutic antibodies from human and animal sources Kling-Evolve enables highly rapid selection of effective neutralizing antibodies against viral escape variants Amsterdam, NLD – 31 […]